Home Science Russia Releases Sputnik V Vaccine To The Citizens

Russia Releases Sputnik V Vaccine To The Citizens

In the latest update, the Russian Health Ministry reported that the first batch of the COVID-19 vaccine, Sputnik V, has been officially released to the citizens of the country.

The Russian Health Ministry reported that the first batch of the country’s COVID-19 vaccine – Sputnik V – has been released into civil circulation. The Ministry further noted that the vaccine that has been jointly developed by the Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) had passed all required quality tests in the laboratories of Roszdravnadzor, a Russian medical device regulator.

WireX August Download

Furthermore, as reported by ANI, the health ministry has stated that the “the delivery of the first batches of the Russian vaccine [Sputnik V] to the country’s regions is planned in the nearest future.”

On 11th August 2020, Russia became the first country to register a COVID-19 vaccine. However, this announcement was met with a lot of backlash and scepticism in the void of proper clinical trials. Nevertheless, twenty countries, including India, UAE, Brazil and Saudi Arabia signed a contract for the controversial vaccine. 

On Monday, Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF), confirmed that India and some other countries would commence the Sputnik V vaccine trials in this month. Dmitriev told ANI:

India has historically been a very important partner of Russia. India is one of the leading countries in production. Around 60 percent of all the vaccines in the world are produced in India. We are in close dialogue with the corresponding ministries and the India government and the leading manufacturer of the country regarding localisation of production of Sputnik V vaccine in India. And we have achieved certain agreements with the leading companies.

Reports claim that Russia will produce about six million doses of the inoculation per month. Its partnership with countries like India is of key importance because India is the largest vaccine manufacturer in the world. 

On Friday, the preliminary result of the vaccine was published in the journal the Lancet. The findings stated that in small human trials, the vaccine successfully produced an antibody response without any side-effects. 


WireX August Download

Muskan Bagrecha
Muskan is an undergraduate student pursuing a Bachelor's in Technology. With a zealous spirit for writing, she finds herself open to the vast realm of learning. She is an avid programmer with a keen interest in technology and science.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

This AI tool predicts onset of Alzheimer’s disease seven years before doctors

An Artificial Intelligence model, developed by IBM Research and pharmaceutical giant Pfizer, can predict Alzheimer’s seven years earlier than doctors with 70% accuracy. The...

Teardown video shows iPhone 12 and 12 Pro share same logic board, battery

A teardown video of the iPhone 12 and iPhone 12 Pro has confirmed the battery life of the models and given iOS lovers a...

Amid #BoycottChina, Chinese firms lead Indian smartphone market with 76% share

The Indian smartphone market showed an 8% growth in the third quarter of 2020, according to a market report by Canalys, a technology market...

Covid vaccine may not be safe in US

Vaccine stakeholders like health officials, hospitals, and pharmaceutical companies are taking stringent measures to prevent Covid vaccines from landing in the hands of criminals....

Recent Comments